CHRISTINE TROMBINO: Open Payments
NPI 1245348846 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$766 in 39 payments from 14 companies in 2025. Trend: 2023 $1,119 · 2024 $982 · 2025 $766
Food & beverage: $766
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $157 |
| Organon LLC | 2 | $142 |
| LEO Pharma Inc. | 4 | $92 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $85 |
| Janssen Biotech, Inc. | 2 | $57 |
| GENZYME CORPORATION | 2 | $57 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| Novartis Pharmaceuticals Corporation | 1 | $33 |
| Arcutis Biotherapeutics, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $19 |
Products named: VTAMA, SKYRIZI, DUPIXENT, ILUMYA, ADBRY, RINVOQ, TREMFYA, COSENTYX.
Industry payments across NE — which companies pay providers there.
